ARTICULATE BIOSCIENCES IS DEVELOPING
Injectable gels for treating arthritis and other soft tissue diseases
Biocompatible, cushioning, & lubricating
Tissue-protecting and function-restoring biomedical polymers
Our first product candidate will relieve pain and restore mobility to sufferers of osteoarthritis.
Spun out of Boston University in 2016, Articulate Biosciences is a preclinical medical device development company. We are internally developing a portfolio of products for several key indications in orthopedics and soft tissue repair. We also provide technology & product development services to small and large clients, with expertise in musculoskeletal polymeric biomaterials and drug formulations.
Internal Product Portfolio
Using our patented ABX platform technology, our mission is to deliver long-lasting pain relief and restoration of mobility to sufferers of osteoarthritis. Through deep understanding of patient and clinician needs, Articulate Biosciences strives to bring back quality of life by eliminating chronic joint pain.
Technology & Product Development Services
We perform joint and outsourced research and development of innovative medical technologies and products in the musculoskeletal space. Our experienced team provides the following services with respect to devices, drug substance & drug product formulations, and packaged medical products:
Design and project planning & management
Manufacturing, analytical testing, and analysis
Preclinical testing (feasibility, safety, and efficacy, for general technology validation and regulatory submissions)
UNITED STATES PATENT COVERING ABX TECHNOLOGY IS ISSUED
PARTICIPANT IN THE NSF I-CORPS PROGRAM
WINNER IN THE MA MEDICAL DEVICE DEVELOPMENT CENTER (M2D2) $100K CHALLENGE
PARTICIPANT IN THE BOSTON UNIVERSITY QUESTROM SCHOOL OF BUSINESS SUMMER ACCELERATOR
ARTICULATE BIOSCIENCES IS FOUNDED